Learn more about the data
Results
Arthrosamid® is an injectable hydrogel implant that delivers long-lasting, proven pain relief without surgery — redefining treatment for knee OA.
Learn more about the data
Arthrosamid® is an injectable hydrogel implant that delivers long-lasting, proven pain relief without surgery — redefining treatment for knee OA.
Canada
Pain Reduction
In all our studies, Arthrosamid® exceeds the MCID of 9 points and improvement is maintained up to 5 years after a single injection.
Close to 80% Response rate
Patients in the under 70 years group reported close to 80% positive response rate following treatment with Arthrosamid®.
Safe & Effective
Arthrosamid® remains safe and effective for its intended use 5 years after treatment.
WOMAC pain subscale change from baseline across studies.
† WOMAC or The Western Ontario and McMaster Universities Osteoarthritis Index is a measure of symptoms and physical function.
LSMeans are modelled/estimated means. The estimated means are using data from the other visits and also the covariates.
The minimum clinically important difference (MCID) represents the smallest improvement considered worthwhile by a patient.
16% of the participants had received arthroplasty surgery for knee OA of the treated knee.
There were no unexpected descriptions of abnormalities that could be associated with the prior treatment with iPAAG in the surgical reports.
“Of these patients, none reported dissatisfaction with the outcome of the surgery and the arthroplasties were well functioning.”
Safety Data
Arthrosamid® is intended to be used for symptomatic treatment of adult patients with knee osteoarthritis.
Contraindications
Treatment with Arthrosamid® may not be suitable for everyone. Your doctor is the best person to advise you.